Drug Makers Toss Authorized Generic Plan

Law360, New York (September 26, 2006, 12:00 AM EDT) -- In hopes of ridding itself of pending litigation, Warner Chilcott Ltd. said Tuesday that it has terminated parts of an agreement with Barr Laboratories Inc. and will allow its rival to market a generic version of a blockbuster birth control drug.

Barr Laboratories, a subsidiary of Barr Pharmaceuticals Inc., now plans to launch a generic version of Ovcon 35 next month.

"Today's action by Warner Chilcott paves the way for Barr to launch the first generic version of Ovcon 35," said Bruce L. Downey, Barr's chief...
To view the full article, register now.